Silence Therapeutics Reports Increased Losses
PremiumCompany AnnouncementsSilence Therapeutics Reports Increased Losses
3M ago
Seven new option listings and one option delisting on July 10th
Premium
The Fly
Seven new option listings and one option delisting on July 10th
4M ago
Silence Therapeutics price target raised to $55 from $42 at Chardan
Premium
The Fly
Silence Therapeutics price target raised to $55 from $42 at Chardan
5M ago
Silence Therapeutics achieves $2M research milestone payment from Hansoh Pharma
PremiumThe FlySilence Therapeutics achieves $2M research milestone payment from Hansoh Pharma
5M ago
Silence Therapeutics’ Zerlasiran Shows Promising Results
Premium
Company Announcements
Silence Therapeutics’ Zerlasiran Shows Promising Results
5M ago
Silence Therapeutics announces 48-week data from Phase 2 study of zerlasiran
Premium
The Fly
Silence Therapeutics announces 48-week data from Phase 2 study of zerlasiran
5M ago
Silence Therapeutics Announces Board Change
PremiumCompany AnnouncementsSilence Therapeutics Announces Board Change
7M ago
Silence Therapeutics Board Veteran Retires
Premium
Company Announcements
Silence Therapeutics Board Veteran Retires
7M ago
Silence Therapeutics Announces Upcoming AGM
Premium
Company Announcements
Silence Therapeutics Announces Upcoming AGM
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100